Viewing nowCombinationAmlobika HCT Tablet 5/40/12.5 Milligrams
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg +1 more
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.

MFDS item code 201805283 · Approved 2018.12.26 · Insurance code 653404280
Treatment of essential hypertension not controlled with amlodipine and olmesartan combination therapy
Essential hypertension patients may take Amlodipine and Olmesartan Medoxomil together. These two medications act to dilate blood vessels and lower blood pressure. However, even when used together, there may be cases where blood pressure control is not adequate. In such situations, it is important to consult healthcare professionals for dose adjustments or additional treatment strategies. Ultimately, these medications help manage blood pressure effectively.
Take 1 tablet once daily with water, with or without food. It is recommended that you take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dosage be adjusted using the individual ingredients (olmesartan medoxomil and amlodipine as monotherapy or combination therapy). However, if blood pressure is not controlled with combination therapy with amlodipine and olmesartan medoxomil, switching directly to this medicine may be considered as follows. The maximum dose of this medicine is 10/40/25mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. The maximum blood pressure-lowering effect occurs within 2 weeks of administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into consideration. The recommended doses are as follows. - 5/20/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy with amlodipine/olmesartan medoxomil 5/20mg. - 5/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy with amlodipine/olmesartan medoxomil 5/40mg or with this medicine 5/20/12.5mg. - 5/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/12.5mg. - 10/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy with amlodipine/olmesartan medoxomil 10/40mg or with this medicine 5/40/12.5mg. - 10/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/25mg or this medicine 10/40/12.5mg. ※ Refer to the following dose escalation schedule. (The content of each ingredient is listed in the order amlodipine/olmesartan medoxomil/hydrochlorothiazide.) 5/20/0mg → 5/20/12.5mg ↓ 5/40/0mg → 5/40/12.5mg → 5/40/25mg ↓ ↓ 10/40/0mg → 10/40/12.5mg → 10/40/25mg □ Patients with renal impairment For patients with mild to moderate renal impairment (creatinine clearance 30-60mL/min), the maximum dose of this medicine is 20/5/12.5mg once daily. Monitoring potassium and creatinine levels is recommended in patients with moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance < 30mL/min). □ Patients with hepatic impairment Use with caution in patients with mild to moderate hepatic impairment. For patients with moderate hepatic impairment, the maximum dose of this medicine is 5/20/12.5mg once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment. This medicine should not be administered to patients with severe hepatic impairment. □ Elderly patients (65 years and older) In general, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and coexisting diseases. Blood pressure should be monitored closely and more frequently in elderly patients. Since experience with the use of this medicine in elderly patients, particularly those aged 75 years and older, is very limited, monitor very carefully when administering this medicine.
Pediatric patients under 18 years of age: Safety and efficacy have not been established; therefore, use of this medicine is not recommended.
This medication can cause severe harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this drug or its components, specific heart, kidney, or liver diseases, and pregnant or breastfeeding women should not take this medication. Patients with excessively low blood pressure, severe heart failure, or acute renal failure should not use this medication. For patients with low blood volume or low salt levels, hypotension may occur, so careful monitoring of the condition is necessary during administration. Patients with impaired kidney function, kidney transplant recipients, patients with renovascular hypertension, or those with liver dysfunction should exercise extra caution when using this medication. This medication lowers blood pressure, which may lead to dizziness or drowsiness, necessitating caution when driving or operating dangerous machinery. Some patients may experience increased sensitivity to sunlight, so sun exposure should be avoided, and if photosensitivity reactions occur, use should be discontinued. While taking this medication, regular blood tests should be conducted to monitor electrolyte levels and kidney function, particularly potassium levels. This medication may interact with other antihypertensive drugs, specific diuretics, lithium, and non-steroidal anti-inflammatory drugs (NSAIDs), so consultation with a physician is advised when used concurrently. Elderly individuals may be more sensitive to this medication, so starting at a lower dose and adjusting cautiously is recommended. In case of overdose, blood pressure may drop excessively, so healthcare personnel should be informed immediately for appropriate treatment. The safety and efficacy of this medication have not been established in children, so its use is not recommended.
Peripheral edema, headache, dizziness, upper respiratory infection, nasopharyngitis, urinary tract infection, sialadenitis, leukopenia, thrombocytopenia, bone marrow suppression, neutropenia, agranulocytosis, hemolytic anemia, aplastic anemia, anaphylactic reaction, drug hypersensitivity, hyperkalemia, hypokalemia, anorexia, diabetes, hypercalcemia, hyperglycemia, hypomagnesemia, hyponatremia, hypochloremia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, hypochloremic alkalosis, hyperamylasemia, confusion, depression, apathy, sensitivity to stimuli, anxiety, mood changes, sleep disturbances, orthostatic dizziness, syncope, taste disturbance, hypertonicity, sensory loss, paresthesia, peripheral neuropathy, drowsiness, fainting, seizures, loss of appetite, tremors, visual disturbances, decreased tearing, worsened myopia, jaundice, vertigo, tinnitus, palpitations, tachycardia, myocardial infarction, arrhythmia, angina, hypotension, flushing, orthostatic hypotension, vasculitis, thrombosis, embolism, cough, bronchitis, shortness of breath, pharyngitis, rhinitis, acute interstitial pneumonia, respiratory distress syndrome, pulmonary edema, diarrhea, nausea, constipation, dry mouth, abdominal pain, changes in bowel habits, bloating, dyspepsia, gastritis, gastric discomfort, gastroenteritis, gingival hyperplasia, paralytic ileus, pancreatitis, vomiting, hepatitis, jaundice, acute cholecystitis, autoimmune hepatitis, hair loss, angioedema, allergic dermatitis, erythema multiforme, erythema, lupus erythematosus-like reaction, pustular rash, exfoliative dermatitis, hyperhidrosis, photosensitivity reaction, pruritus, purpura, Quincke's edema, rash, recurrence of cutaneous lupus erythematosus, toxic skin necrosis, Stevens-Johnson syndrome, urticaria, muscle spasms, joint swelling, muscle weakness, ankle edema, arthralgia, arthritis, low back pain, paresis, myalgia, bone pain, frequent urination, acute kidney failure, hematuria, urination disorders, nocturia, interstitial nephritis, renal failure, erectile dysfunction, gynecomastia, asthenia, fatigue, chest pain, fever, influenza-like symptoms, lethargy, malaise, edema, pain, facial swelling, elevated serum creatinine, elevated blood urea, elevated serum uric acid, decreased serum potassium, elevated gamma-glutamyl transferase, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated liver enzymes, elevated creatine phosphokinase, weight loss, weight gain, rhabdomyolysis, chronic malabsorption syndrome, intestinal vascular edema, altered consciousness, eczema, limb pain, mild decrease in mean hemoglobin and hematocrit levels
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It should also be kept away from extremely hot or cold places, ideally stored at room temperature between 1 degree and 30 degrees Celsius.
Pale yellow, round, film-coated tablet
28 tablets (14 tablets/PTP *2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg +1 more
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.